Concepedia

Emily H. Pilkington

EH

Statistics

Publications

32

Citations

1.8K

H-Index

24

Active since

2015

Affiliations

Monash University(Current)

University of Warwick

Clemson University

The University of Melbourne

Australian Regenerative Medicine Institute

Emily H. Pilkington is an author at Monash University specializing in life sciences, amyloid formation, and nanomedicine.

ORCID

Publications per year

2015–2024

32

Publications

32

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

Yi Ju, Wen Shi Lee, Emily H. Pilkington et al. · ACS Nano · 2022 · 333 citations

, , +17

Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition

Praveen Nedumpully-Govindan, Aleksandr Käkinen, Emily H. Pilkington et al. · Scientific Reports · 2016 · 125 citations · Full text

, , +17

Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer

Esteban N. Gurzov, Bo Wang, Emily H. Pilkington et al. · Small · 2016 · 102 citations · Full text

, , +17

<i>In vivo</i> delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression

Azizah Algarni, Emily H. Pilkington, Estelle J. A. Suys et al. · Biomaterials Science · 2022 · 90 citations

, , +17

Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network

Mai N. Vu, Hannah G. Kelly, Adam K. Wheatley et al. · Small · 2020 · 88 citations · Full text

, , +17

1–5 of 32